InnovAge (INNV) Set to Release Earnings on Tuesday

InnovAge (NASDAQ:INNV) is projected to announce its Q1 2027 results after the market closes on Tuesday, November 3rd. Analysts expect the company to announce earnings of $0.0859 per share and revenue of $257.23 million for the quarter. Individuals may review the information on the company’s upcoming Q1 2027 earnings results page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 5:00 PM ET.

InnovAge (NASDAQ:INNV) last issued its earnings results on Tuesday, September 8th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). The company had revenue of $261.95 million for the quarter, compared to analysts’ expectations of $238.33 million. InnovAge had a negative return on equity of 1.03% and a negative net margin of 0.26%. On average, analysts expect InnovAge to post $0.43 EPS for the current fiscal year and $0.48 EPS for the next fiscal year.

InnovAge Trading Down 2.9%

INNV opened at $9.27 on Tuesday. The company has a market capitalization of $1.26 billion, a P/E ratio of -463.50 and a beta of 0.15. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.23. InnovAge has a 52 week low of $3.93 and a 52 week high of $12.64. The stock’s fifty day moving average is $9.97 and its two-hundred day moving average is $8.96.

Insider Activity at InnovAge

In related news, major shareholder Aggregator Lp Ignite sold 10,000,000 shares of the firm’s stock in a transaction dated Thursday, September 24th. The shares were sold at an average price of $9.25, for a total transaction of $92,500,000.00. Following the completion of the sale, the insider directly owned 102,576,555 shares in the company, valued at approximately $948,833,133.75. This trade represents a 8.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nicole Damato sold 23,814 shares of the stock in a transaction that occurred on Friday, September 25th. The stock was sold at an average price of $8.70, for a total value of $207,181.80. Following the completion of the transaction, the insider owned 304,897 shares of the company’s stock, valued at $2,652,603.90. The trade was a 7.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 13,027,216 shares of company stock valued at $120,489,535. 1.00% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on INNV. Weiss Ratings restated a “sell (d-)” rating on shares of InnovAge in a report on Thursday, August 13th. Wall Street Zen lowered shares of InnovAge from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 18th. Finally, KeyCorp lifted their target price on InnovAge from $13.00 to $14.00 and gave the stock an “overweight” rating in a report on Wednesday, September 9th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, InnovAge presently has a consensus rating of “Reduce” and a consensus price target of $10.50.

InnovAge Company Profile

InnovAge (NASDAQ: INNV) is a healthcare services company that provides comprehensive care for older adults through the Program of All-Inclusive Care for the Elderly (PACE). Its model is designed to help eligible seniors remain living in their homes and communities rather than moving to nursing facilities, while coordinating medical, social, and supportive services through an integrated care program.

InnovAge’s services may include primary and specialty medical care, nursing, physical and occupational therapy, behavioral health, pharmacy services, dentistry, vision care, meals, transportation, social services, and in-home support.